feed,title,long_url,short_url
MedRxiv,Antibody responses to known and unknown SARS-CoV-2 infections after mRNA vaccine booster,https://medrxiv.org/cgi/content/short/2022.05.06.22274719v1?rss=1,https://bit.ly/3FnyHJa
MedRxiv,Covid-19 vaccine effectiveness against general SARS-CoV-2 infection from the omicron variant: A retrospective cohort study,https://medrxiv.org/cgi/content/short/2022.05.06.22274771v1?rss=1,https://bit.ly/3FnTc8P
MedRxiv,Impact of COVID-19 non-pharmaceutical interventions on pneumococcal carriage prevalence and density in Vietnam,https://medrxiv.org/cgi/content/short/2022.05.05.22274646v1?rss=1,https://bit.ly/3N2uEEZ
MedRxiv,Longitudinal analysis reveals elevation then sustained higher expression of autoantibodies for six months after SARS-CoV-2 infection,https://medrxiv.org/cgi/content/short/2022.05.04.22274681v1?rss=1,https://bit.ly/3MZD7sk
MedRxiv,Deep learning identified genetic variants associated with COVID-19 related mortality,https://medrxiv.org/cgi/content/short/2022.05.05.22274731v1?rss=1,https://bit.ly/3P3kCoS
MedRxiv,Managing COVID-19 in an Australian designated isolation facility: Implications for current and future healthcare crises,https://medrxiv.org/cgi/content/short/2022.05.05.22274702v1?rss=1,https://bit.ly/37o2VPM
MedRxiv,Screening for safe opening of universities under Omicron and Delta variants of COVID-19: When less is more,https://medrxiv.org/cgi/content/short/2022.05.04.22274667v1?rss=1,https://bit.ly/3kP4I3v
MedRxiv,Changes in English medication safety indicators throughout the COVID-19 pandemic: a federated analysis of 57 million patients' primary care records in situ using OpenSAFELY,https://medrxiv.org/cgi/content/short/2022.05.05.22273234v1?rss=1,https://bit.ly/3LVW9zS
MedRxiv,"Post-acute health care burden after SARS-CoV-2 infection: A retrospective cohort study among 530,892 adults",https://medrxiv.org/cgi/content/short/2022.05.06.22274782v1?rss=1,https://bit.ly/3yk1Fbo
